IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population
Ye, D.1; Sun, Y. H.2; Wei, Q.3; Yao, X.4; Ye, Z. Q.5; Huang, Y. R.6; Zhang, W.7; Yang, Y.8; Tian, Y.9; Na, Y. Q.10
刊名EUROPEAN JOURNAL OF CANCER
2013-09-01
suppl.2页:S706-S706
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000326843604289
引用统计
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67025
专题北京大学临床肿瘤学院
作者单位1.Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
2.Peking Univ, Beijing Canc Hosp, Beijing 100871, Peoples R China
3.Peking Univ, Shougang Hosp, Beijing 100871, Peoples R China
4.Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China
5.Sichuan Univ, West China Hosp, West China Sch Med, Chengdu 610064, Peoples R China
6.Chinese PLA, Sch Med, Chinese PLA Gen Hosp, Beijing, Peoples R China
7.Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Wuhan 430074, Peoples R China
8.Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai 200030, Peoples R China
9.Nanjing Med Univ, Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China
10.Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Ye, D.,Sun, Y. H.,Wei, Q.,et al. A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population[J]. EUROPEAN JOURNAL OF CANCER,2013,suppl.2:S706-S706.
APA Ye, D..,Sun, Y. H..,Wei, Q..,Yao, X..,Ye, Z. Q..,...&Na, Y. Q..(2013).A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population.EUROPEAN JOURNAL OF CANCER,suppl.2,S706-S706.
MLA Ye, D.,et al."A randomized open-label study comparing the docetaxel plus prednisone regimen versus mitoxantrone plus prednisone regimen for metastatic hormone refractory prostate cancer in Chinese population".EUROPEAN JOURNAL OF CANCER suppl.2(2013):S706-S706.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Ye, D.]的文章
[Sun, Y. H.]的文章
[Wei, Q.]的文章
百度学术
百度学术中相似的文章
[Ye, D.]的文章
[Sun, Y. H.]的文章
[Wei, Q.]的文章
必应学术
必应学术中相似的文章
[Ye, D.]的文章
[Sun, Y. H.]的文章
[Wei, Q.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。